Fibroblast growth factor-2 regulates myocardial infarct repair: Effects on cell proliferation, scar contraction, and ventricular function

American Journal of Pathology

Volumn 171, Issue 5, 2007, Pages 1431-1440

  Virag, Jitka A I ^a,c   Rolle, Marsha L ^a   Reece, Julia ^a   Hardouin, Sandrine ^b   Feigl, Eric O ^a   Murry, Charles E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REGENERATION; TISSUE REPAIR; WOUND HEALING;

EID: 36348982148     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070003     Document Type: Article

References (43)

1. Boyle MP, Weisman HF: Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 1993, 88:2872-2883
2. Virag JI, Murry CE: Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 2003, 163:2433-2440
3. Detillieux KA, Sheikh F, Kardami E, Cattini PA: Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 2003, 57:8-19
4. Kawai K, Suzuki S, Tabata Y, Ikada Y, Nishimura Y: Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 2000, 21:489-499
5. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C: Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1998, 95:5672-5677
6. Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T: Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 1999, 104:709-719
7. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T: Fibroblast growth factor 2 control of vascular tone. Nat Med 1998, 4:201-207
8. Coffin JD, Florkiewicz RZ, Neumann J, Mort-Hopkins T, Dorn GW II, Lightfoot P, German R, Howies PN, Kier A, O'Toole BA: Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Biol Cell 1995, 6:1861-1873
9. Ismail J, Poppa V, Kemper L, Scatena M, Giachelli C, Douglas J, Murry CE: Immunohistologic labeling of murine endothelium. Cardiovasc Pathol 2003, 12:82-90
10. Reinecke H, Murry CE: Cell grafting for cardiac repair. Methods Mol Biol 2003, 219:97-112
11. Hutchins GM, Bulkley BH: Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978, 41:1127-1132
12. Greenberg SR: Response of the renal supporting tissues to chronic fluoride exposure as revealed by a special technique. Urol Int 1986, 41:91-94
13. Darby I, Skalli O, Gabbiani G: α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990, 63:21-29
14. Hardouin SN, Richmond KN, Zimmerman A, Hamilton SE, Feigl EO, Nathanson NM: Altered cardiovascular responses in mice lacking the M(1) muscarinic acetylcholine receptor. J Pharmacol Exp Ther 2002, 301:129-137
15. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE: Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994, 266:H1588-H1595
16. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M: Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994, 94:623-630
17. Kawasuji M, Nagamine H, Sakakibara N, Takemura H, Watanabe Y: Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor. Ann Thorac Surg 2000, 69:1155-1161
18. Ninomiya M, Koyama H, Miyata T, Hamada H, Miyatake S, Shigematsu H, Takamoto S: Ex vivo gene transfer of basic fibroblast growth factor improves cardiac function and blood flow in a swine chronic myocardial ischemia model. Gene Ther 2003, 10:1152-1160
19. Sato K, Wu T, Laham RJ, Johnson RB, Douglas P, Li J, Sellke FW, Bunting S, Simons M, Post MJ: Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 2001, 37:616-623
20. Laham RJ, Simons M, Tofukuji M, Hung D, Sellke FW: Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: insight into ischemia-induced reduction in endothelium-dependent vasodilatation. J Thorac Cardiovasc Surg 1998, 116:1022-1028
21. Breuing K, Andree C, Helo G, Slama J, Liu PY, Eriksson E: Growth factors in the repair of partial thickness porcine skin wounds. Plast Reconstr Surg 1997, 100:657-664
22. Marks MG, Doillon C, Silver FH: Effects of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices. J Biomed Mater Res 1991, 25:683-696
23. Scheinowitz M, Kotlyar A, Zimand S, Ohad D, Leibovitz I, Bloom N, Goldberg I, Nass D, Engelberg S, Savion N, Eldar M: Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats. Exp Physiol 1998, 83:585-593
24. Scheinowitz M, Kotlyar AA, Zimand S, Leibovitz I, Varda-Bloom N, Ohad D, Goldberg I, Engelberg S, Savion N, Eldar M: Effect of basic fibroblast growth factor on left ventricular geometry in rats subjected to coronary occlusion and reperfusion. Isr Med Assoc J 2002, 4:109-113
25. Pellieux C, Foletti A, Peduto G, Aubert JF, Nussberger J, Beermann F, Brunner HR, Pedrazzini T: Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J Clin Invest 2001, 108:1843-1851
26. Reidy MA: Factors controlling smooth-muscle cell proliferation. Arch Pathol Lab Med 1992, 116:1276-1280
27. Lindner V, Reidy M: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991, 88:3739-3743
28. Pintucci G, Moscatelli O, Saponara F, Biernacki PR, Baumann FG, Bizekis C, Galloway AC, Basilico C, Mignatti P: Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J 2002, 16:598-600
29. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK, Goodell MA: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001, 107:1395-1402
30. Bryant SR, Bjercke RJ, Erichsen DA, Rege A, Lindner V: Vascular remodeling in response to altered blood flow is mediated by fibroblast growth factor-2. Circ Res 1999, 84:323-328
31. Pfeffer MA, Brunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990, 81:1161-1172
32. Gabbiani G: The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503
33. Gabbiani G, Badonnel MC: Contractile events during inflammation. Agents Actions 1976, 6:277-280
34. Chaponnier C, Gabbiani G: Pathological situations characterized by altered actin isoform expression. J Pathol 2004, 204:386-395
35. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ: Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001, 89:201-210
36. Padua RR, Sethi R, Dhalla NS, Kardami E: Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem 1995, 143:129-135
37. Padua RR, Merle PL, Doble BW, Yu CH, Zahradka P, Pierce GN, Panagia V, Kardami E: FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C. J Mol Cell Cardiol 1998, 30:2695-2709
38. Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J, Cattini PA, Dixon IM, Kardami E: Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol 2002, 282:H1071-H1080
39. House SL, Branch K, Newman G, Doetschman T, Schultz JEJ: Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade. Am J Physiol 2005, 289:H2167-H2175
40. Liao S, Porter D, Scott A, Newman G, Doetschman T, Schultz JEJ: The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: The role of JNK signaling. J Mol Cell Cardiol 2007, 42:106-120
41. Sheikh F, Sontag DP, Fandrich RR, Kardami E, Cattini PA: Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol 2001, 280:H1039-H1050
42. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz JEJ: Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation 2003, 108:3140-3148
43. Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E: Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc Res 2004, 62:154-166